NovoCure Limited Ordinary Shares NVCR
$16.95
-2.47%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-07-23 | View → |
| 10-Q | 10-Q | 2026-07-23 | View → |
| 4 | PRIMARY DOCUMENT | 2026-07-01 | View → |
| 4 | PRIMARY DOCUMENT | 2026-07-01 | View → |
| 4 | PRIMARY DOCUMENT | 2026-07-01 | View → |
| 4 | PRIMARY DOCUMENT | 2026-07-01 | View → |
| 8-K | 8-K | 2026-06-30 | View → |
| 8-K | 8-K | 2026-06-18 | View → |
| 8-K | 8-K | 2026-06-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-03 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-03 | View → |
| 8-K | 8-K | 2026-04-30 | View → |
| 10-Q | 10-Q | 2026-04-30 | View → |
| 4 | PRIMARY DOCUMENT | 2026-04-28 | View → |
| DEF 14A | DEF 14A | 2026-04-20 | View → |
| 8-K | 8-K | 2026-04-09 | View → |
| 8-K | 8-K | 2026-03-26 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-05 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-05 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $16.95
- Market Cap
- $2.05 billion
- 52-Week Range
- $9.82 – $21.45
- Average Volume
- 1.62 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.